GSK on X: We have submitted the circular and prospectus in relation to our proposed demerger of our consumer healthcare business @Haleon_health to the FCA for approval and expect to publish the
4.9 (687) · $ 16.99 · In stock
Former GSK consumer health arm Haleon posts 16.1% jump in
Investors
GSK Consumer Healthcare to be renamed Haleon after demerger
Investors
GSK consumer chief plans deal spree after split from pharma
GSK Consumer Healthcare to be renamed Haleon after demerger
Investors
Investors
Haleon CMD to demerger archive
You may also like